Protein intake in patients with colorectal or lungcancer when receiving a nutritional supplement

INTERVENTION: Duration of intervention: approximately 13 weeks Intervention group: receiving two units of test product per day for oral intake for a period of approximately 13 weeks. Control group: receiving standard of care, ie nutritional support as regularly provided by the hospital, CONDITION: Colorectal cancer, Colorectal, Lung cancer ; ; PRIMARY OUTCOME: To assess protein intake at the end of the first treatment cycle SECONDARY OUTCOME: ‐ Proportion of subjects with a protein intake above the lower limit of the ESPEN recommendations for protein intake ; ; ‐ Body weight ; INCLUSION CRITERIA: 1. Histologically proven CRC stage IIB, III or IV or histologically or cytologically proven NSCLC stage III or IV 2. Eligible and scheduled for first line chemotherapy, concurrent chemoradiotherapy or immunotherapy treatment with a planned duration of at least 12 weeks 3. Performance status Eastern Cooperative Oncology Group (ECOG) score 0 or 1 4. Age ¡Ý 18 years 5. Written informed consent